Tokyo, Japan

Hidetaka Seo

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Saitama, JP (2010 - 2017)
  • Tokyo, JP (2011 - 2020)

Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Hidetaka Seo: A Visionary Innovator in the World of Inventors

Introduction:

Hidetaka Seo, a renowned inventor based in Tokyo, JP, is known for his relentless pursuit of innovation and his passion for creating solutions to complex challenges, establishing him as a true visionary in the field of inventors.

Latest Patents:

With an impressive portfolio of 7 patents, Hidetaka Seo's latest groundbreaking invention focuses on the development of an Anti-semaphorin 3A antibody. This innovation addresses the effective prevention and treatment of diseases involving the Sema 3A protein, such as Alzheimer's disease, inflammatory immune diseases, autoimmune diseases, and more.

Career Highlights:

Throughout his career, Hidetaka Seo has made significant contributions to the field of biotechnology, particularly during his tenure at Riken Corporation and Chiome Bioscience Inc. His work has revolutionized the approach to treating neurodegenerative diseases and inflammatory conditions, showcasing his unwavering dedication to advancing medical science.

Collaborations:

Hidetaka Seo has collaborated with esteemed colleagues such as Kunihiro Ohta and Takehiko Shibata. These partnerships have led to the development of innovative solutions and have further established his reputation as a leader in the realm of inventors and patent holders.

Conclusion:

In conclusion, Hidetaka Seo's innovative spirit, coupled with his commitment to tackling pressing healthcare challenges, sets him apart as a true visionary in the world of inventors. His contributions continue to shape the landscape of medical innovation, offering hope and healing to those affected by complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…